Navigation Links
Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
Date:7/17/2012

RESEARCH TRIANGLE PARK, N.C., July 17, 2012 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, today announced plans to initiate a safety trial of a novel, inhaled formulation of alpha1-proteinase inhibitor [Human] later this year.  In April, the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Grifols' inhaled alpha1 formulation as a treatment for cystic fibrosis, an inherited disease that can cause life-threatening lung infections. Orphan drug designation is granted to encourage the development of treatments that prevent, diagnose or treat rare diseases that affect fewer than 200,000 people per year in the U.S.

"Grifols is committed to developing new therapies that address the debilitating symptoms of chronic lung disease," said Kim Hanna, vice president of clinical research development at Grifols. "The orphan drug designation represents another milestone in the growth of our alpha1 program, and we're excited to pursue clinical trials with an aerosol formulation of this important therapy."

Grifols currently leads the market in alpha1-proteinase inhibitors with its intravenous therapy PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human])(A1-PI), indicated for the treatment of alpha1-antitrypsin (AAT) deficiency. This rare, genetic disorder can result in the development of emphysema due to low circulating levels of the alpha1 protein in the lungs.

PROLASTIN®, the predecessor to PROLASTIN-C, was the first FDA-approved product to treat AAT deficiency and remained so for nearly 17 years. Grifols is developing its next-generation alpha­1-proteinase inhibitor as an inhaled formulation.

About Orphan Drug Designation

Orphan drug designation is granted to companies to encourage the development of treatments that prevent, diagnose or treat rare conditions that affect fewer than 200,000 people per year in the U.S. The designation provides incentives such as t
'/>"/>

SOURCE Grifols
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
2. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
3. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
6. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
7. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Senate HELP Committee OKs Food and Drug Administration Safety And Innovation Act
10. PDR and the iHealth Alliance Announce New Drug Safety Certification for EHRs
11. Physician-Patient Alliance for Health & Safety: Monitoring Technology for PCA Pumps Can Prevent Adverse Events: So Why Are Hospitals Not Using It?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mike Rowe , spokesperson and reality television personality, will ... 2015 ThoughtSpot conference and tradeshow, which runs from ... Nev. Best known for his ... Channel,s, "Dirty Jobs," Mr. Rowe spent a decade traveling across ... whose hard work, sacrifice and value aren,t always recognized. Prior ...
(Date:7/28/2015)... 2015 Baebies, Inc. today announced the completion ... The oversubscribed round of financing included key investors Rex ... Cunning Capital, Triad, LLC, the Duke Angel Network and ... of Advanced Liquid Logic,s (ALL) former investors including Charleston ... "Rex is pleased to support this promising ...
(Date:7/28/2015)... 28, 2015  Zipnosis, the first virtual care solution to ... launch their own branded virtual care service line, announced an ... CareNow is currently in use. ... As health ... recognize the value of providing their own branded online care ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3
(Date:7/28/2015)... ... ... Egg freezing is becoming an increasingly popular option for family ... Dr. Michael Kettel explained in an article from the San Diego Union-Tribune ... generations who had to make choices between their fertility and their career or personal ...
(Date:7/28/2015)... ... ... According to WFTV on July 15th heroin overdose rates have ... According to recent statistic Orlando suffers at least one death weekly as a direct ... and law enforcement officials are struggling to keep apace with its distribution. Officers rely ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Directors has authorized the Company, from time to time and depending on market ... of up to $25 million. Repurchases will be made in open market or ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... Every ... professionals or to use extreme caution when lighting fireworks in their own neighborhoods. Unfortunately, ... and discussed in a July 3, 2015 USA Today article " Eye Injuries Caused ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... has won the 2015 NCW Eco-Excellence Award for the Nutrition Beverage category. Established ... lifestyle industries and elevate companies that stand out for their social and environmental ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Coco Libre Wins 2015 NCW Eco-Excellence Award 2
... 6 a $5 million investment through the Texas Emerging Technology ... at Houston to launch a new trauma research center led ... for Translational Injury Research (CeTIR) will open in September. , ... of 1 and 44. Every year, injury accounts for 16,000 ...
... 14th,the Aspen Institute Health Stewardship Project will release ... Obama, and Hillary,Rodham Clinton, to a questionnaire on ... provide analysis of the candidates, responses,and discuss the ... Zogby,International., The co-chairs will comment on where ...
... CNN Anchor Soledad O,Brien served as Master of ... for Lupus, Gala raised nearly $1.5 million ... 8 Grammy Award-winning,performer Patti LaBelle entertained a ... of America Awards Gala last night with her ...
... have devoted countless years of collective brainpower to rescuing ... week researchers at the University of Washington will try ... discoveries, perhaps even finding a cure for HIV., A ... competitive sport. Introductory levels teach the rules, which are ...
... Receive this Honor, AUSTIN, Texas, May 8 ... that the hospital network was,selected as one of three ... honor bestowed by the State of Texas based upon,world ... Quality Texas Foundation, is based on St.,David,s HealthCare,s commitment ...
... self-contained breathing,apparatus (SCBA), designed by Draeger Safety, ... the new tough NFPA 1982, 2007 standards ... everyday., (Photo: http://www.newscom.com/cgi-bin/prnh/20080508/NETH078 ), ... apparatus provides,a high level of protection in ...
Cached Medicine News:Health News:Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research 2Health News:Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research 3Health News:Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research 4Health News:Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 2Health News:Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala 3Health News:Computer game's high score could earn the Nobel Prize in medicine 2Health News:Computer game's high score could earn the Nobel Prize in medicine 3Health News:Computer game's high score could earn the Nobel Prize in medicine 4Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 2Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 3Health News:Draeger Introduces the AirBoss Series Self-Contained Breathing Apparatus Approved to: NFPA 1981, 2007 Standards 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: